Results 91 to 100 of about 8,883 (145)

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.

Developments in biologicals, 2002
A generic approach to inducing high level CD8+ T cell responses would be of value for prophylactic and therapeutic immunisation against several infectious diseases. However, it has been very difficult to achieve such immune responses using available vaccination strategies. Malaria is one of several diseases against which a new generation of better CD8+
Hill, A, Reece, W, Gothard, P, Moorthy, V, Roberts, M, Flanagan, K, Plebanski, M, Hannan, C, Hu, J, Anderson, R, Degano, P, Schneider, J, Prieur, E, Sheu, E, Gilbert, S   +14 more
openaire   +2 more sources

Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer. [PDF]

Front Immunol, 2023
Niavarani SR, St-Cyr G, Daniel L, Lawson C, Giguère H, Alkayyal AA, Tai LH.   +6 more
europepmc   +1 more source

Heterologous Prime-Boost Vaccination with GRA35-Encoding DNA and mRNA Vaccines Enhances Protective Immunity Against <i>Toxoplasma gondii</i> Infection in Mouse Models. [PDF]

Microorganisms
Chen S, Li R, Zhu Y, Sun J, Chen J.
europepmc   +1 more source

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study. [PDF]

Int J Infect Dis, 2023
Kohmer N, Stein S, Schenk B, Grikscheit K, Metzler M, Rabenau HF, Widera M, Herrmann E, Wicker S, Ciesek S.   +9 more
europepmc   +1 more source

Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse. [PDF]

Cancer Immunol Immunother
Huang CH, Chen JY, Chang HY, Hong WZ, Jiang YW, Lee CY, Wu CH, Lin YS, Tsai YY, Kao WL, Chao KSC, Huang KC.   +11 more
europepmc   +1 more source

Revival of the heterologous prime-boost technique in COVID-19: An outlook from the history of outbreaks. [PDF]

Health Sci Rep, 2022
Siddiqui A, Adnan A, Abbas M, Taseen S, Ochani S, Essar MY.   +5 more
europepmc   +1 more source

A pilot study on a heterologous prime-boost approach for inducing an immune response against double-layered human rotavirus particles. [PDF]

BMC Res Notes
Alesheikh S, Tazarghi A, Tabarraei A, Kianmehr Z, Akhondi S, Soleimanjahi H, Azimi SA, Razavi Nikoo H.   +7 more
europepmc   +1 more source

Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study. [PDF]

Hum Vaccin Immunother, 2023
Tawinprai K, Jungsomsri P, Pinijnai O, Tavonvunchai F, Lievjaroen A, Suwannaroj P, Siripongboonsitti T, Porntharukchareon T, Sornsamdang G, Ungtrakul T.   +9 more
europepmc   +1 more source

Heterologous Prime-Boost with ChAdOx1-VZV Establishes Dual-Layer Immunogenicity Conferring Protective Potential Against Herpes Zoster. [PDF]

Vaccines (Basel)
Zhao J, Shao J, Sui X, Wei M, Ma X, Xu Z, Zhu T.   +6 more
europepmc   +1 more source

The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies. [PDF]

Hepatology
Strain R, Edmans M, Montalvo Zurbia-Flores G, Frumento N, Brown A, Hutchings C, Board C, Knight C, Flyak AI, Flyak AI, Bailey J, Lauer G, Cox A, Klenerman P, Barnes E.   +14 more
europepmc   +1 more source